Encainide
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
4-methoxy-N-[2-(1-methyl-2-piperidin-1-ylethyl)phenyl]benzamide | |
Clinical data | |
Trade names | Enkaid |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
MedlinePlus | a605040 |
Legal status | Withdrawn |
Identifiers | |
CAS number | 66778-36-7 |
ATC code | C01BC08 |
PubChem | CID 48041 |
DrugBank | DB01228 |
ChemSpider | 43697 |
UNII | SY3J0147NB |
KEGG | D07894 |
ChEBI | CHEBI:4788 |
Chemical data | |
Formula | C22H28N2O2 |
Mol. mass | 352.47 g/mol |
SMILES
| |
| |
(what is this?) (verify) | |
Encainide (trade name Enkaid) is a class Ic antiarrhythmic agent. It is no longer used because of its frequent proarrhythmic side effects.[1]
See also
References
- ↑ Echt, D. S.; Liebson, P. R.; Mitchell, L. B.; Peters, R. W.; Obias-Manno, D.; Barker, A. H.; Arensberg, D.; Baker, A.; Friedman, L.; Greene, H. L.; Huther, M. L.; Richardson, D. W. (1991). "Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo". New England Journal of Medicine 324 (12): 781–788. doi:10.1056/NEJM199103213241201. PMID 1900101.
|
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.